Technophage honored with a Healthcare & Pharmaceutical Award
For eight years in a row, the Healthcare & Pharmaceutical Awards have recognized the pioneers transforming our healthcare field. We are thrilled to announce that Technophage has been recognized as the “Most Innovative Biopharmaceutical Company 2023 –...
TZ-161 one step closer to clinical trials in spinal cord injury
Technophage is thrilled to share that TZ-161 product is now one step closer to potentially becoming a pioneering repurposed treatment for patients suffering from acute spinal cord injury. This innovative product, currently undergoing clinical trial application in...
Miguel Garcia unveils plans for the Bio-Hub Agenda at the First Annual Meeting
Miguel Garcia, the CEO of Technophage S.A. and LxBio – Pharmaceuticals S.A., recently presented the Bio-Hub Project during the First Annual Meeting of Mobilizing and Green Agendas for Business Innovation, as part of the Recovery and Resilience Plan (PRR). The...